RE: AstraZeneca9 Aug 2020 14:56
Mmm - I think its OK to speculate - assumptions to test is this company not big enough to commercialise (particularly) promotion and a deal with a bigger player especially involving initial milestone payments would be more profitable and/or less risky.
Players that are in this space with effective sales teams (therefore minimal marginal cost) are AZ, GSK, Novartis, Chiesi.
Let the games commence